Jagsonpal Pharmaceuticals Ltd

NSE: JAGSNPHARM · BSE: 507789 · Pharmaceuticals & Biotechnology · 45 announcements

Share price: ₹235.99
Market cap: ₹1,557 Cr
Revenue (annual): ₹287.2 Cr
Net profit (annual): ₹43.08 Cr
P/E (TTM): 34.2×Sector 47.4×
Promoter holding: 69.05%+1.16% QoQ
FII holding: 2.30%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Merger & Restructuring 11 Employee Stock Options 9 Financial Results 4 Earnings Call 4 Annual General Meeting 4 Management Change 3 Other Announcement 2 Dividend 2 Board Meeting Outcome 2 Results Update 1 Business Update 1 Board Meeting Date 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

27 Apr 2026 19:38 IST BSE

Results Update

Jagsonpal Pharmaceuticals Results Update

Jagsonpal Pharmaceuticals reported FY26 revenue of ₹287.2 Crore, a 7% YoY increase, with PAT rising 19% to ₹44.6 Crore. The Board approved a ₹40 Crore share buyback at ₹250 per share and proposed a 200% dividend. Growth was driven by strong demand in core therapies like Gynaecology and Orthopaedics.

Value: ₹287.2 Cr

Read the filing ↗